We believe this site might serve you best:

United States

English Continue

This country code will remain if no action is taken to change it.

Don't see your country?
Promega Corporation

KDR Kinase Enzyme System

See All Kinase Enzyme Systems
Recombinant human KDR (amino acids 789–end) was expressed by baculovirus in Sf9 insect cells using an N-terminal GST tag. KDR (or kinase insert domain receptor) is a growth factor receptor tyrosine kinase that was originally isolated from human endothelial cells where it plays a pivotal role in endothelial cell proliferation and differentiation. KDR and its mouse homolog Flk1 bind VEGF with high affinity and are implicated in the development of new blood vessels (angiogenesis). The expression levels of VEGF and KDR are highly correlated during the normal development of the ocular vas...

Expand to Read More »

  • Share
  • Print
  • Email
  • Prices valid for US customers only
Product Size Conc. Catalog # *List Price Order QTY Add to Cart

KDR Kinase Enzyme System

Close Window

KDR Kinase Enzyme System

 Components

10μg
- V2681 $ 406.00 Add to cart

KDR Kinase Enzyme System

Close Window

KDR Kinase Enzyme System

 Components

1mg
- V2682 $ 5,990.00 Add to cart

ADP-Glo™ Kinase Assay + KDR Kinase Enzyme System

Close Window

ADP-Glo™ Kinase Assay + KDR Kinase Enzyme System

 Components

  • KDR Kinase Enzyme System

    V26811 x 10μg
  • ADP-Glo™ Kinase Assay

    V91011 x 1,000 assays
1 each
- V9471 $ 808.00 Add to cart


You Also May Be Interested In

Storage Conditions

Upon receipt, centrifuge the kinase and dispense it into smaller quantities. Store the kinase at –70°C and the rest of the components at –20°C.

For product intended use please see Patents & Disclaimers tab.

Use Restrictions

V2681, V2682, V9471 For Research Use Only. Not for Use in Diagnostic Procedures.

Patents - Disclaimers

V9471 U.S. Pat. Nos. 7,083,911, 7,452,663 and 7,732,128 and other patents.

V9471 U.S. Pat. No. 7,700,310 and other patents and patents pending.

V9471 U.S. Pat. No. 7,741,067 and other patents and patents pending.

V9471 U.S. Pat. Nos. 6,602,677, 7,241,584 and 8,030,017 and other patents and patents pending.

V9471 U.S. Pat. No. 8,183,007 and other patents pending.

V9471 Licensed from Lonza Nottingham Ltd. under U.S. Pat. Nos. 6,599,711 and 6,911,319 and other pending and issued patents.

V9471 The method of recombinant expression of Coleoptera luciferase is covered by U.S. Pat. Nos. 5,583,024, 5,674,713 and 5,700,673.

It appears that you have Javascript disabled. Our website requires Javascript to function correctly. For the best browsing experience, please enable Javascript.

Scientists at Your Service

Scientists at Your Service

We offer a range of services to help you succeed using Promega technologies. From product training to set up of automated systems and development of custom applications—our scientific support goes beyond the basics.

Ask us! We are here to help you.